47 results on '"Preda, L."'
Search Results
2. BLUE SKY STUDY: RADIOMICS FEATURES AS PREDICTIVE MARKERS OF PROGRESSION-FREE SURVIVAL IN STAGE III, PD-L1 POSITIVE NSCLC
3. MRI AND CT IMAGES OF LUNG CANCER PATIENTS: RADIOMIC ANALYSIS AND FEATURES EXTRACTION SOFTWARE COMPARISON
4. Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936)
5. PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.
6. PO-2100 Radiomic features and PFS post-PACIFIC in the Blue Sky Observational Study on stage 3 PDL1+ NSCLC.
7. PO-1855 application of advanced mri techniques in patients affected by meningioma treated with protontherapy
8. PD-0828 Risk factors for the development of maxillary osteoradionecrosis in ACC patients treated with CIRT
9. 114P Preliminary results of the “Blue Sky Radiomics” study on stage III NSCLC patients treated with chemo-radiation and consolidation immunotherapy
10. PO-1951 Comparison between the use of PET and MRI 3.0 T in meningiomas
11. PO-1948 comparison between the use of PET-CT and high-field MRI 3.0T in adenoid cystic carcinoma
12. PO-0850: Proton Beam Reirradiation In Head And Neck Patients at CNAO: preliminary results.
13. A novel framework for spatial normalization of dose distributions in voxel-based analyses of brain irradiation outcomes
14. A Novel Framework for Spatial Normalization of Dose Distributions in Voxel-Based Analyses of Brain Irradiation Outcomes
15. PO-0741 Active spot-scanning proton therapy for intracranial meningiomas: CNAO experience
16. EP-1456 Clinical impact of re-irradiation with carbon ion radiotherapy for locally recurrent rectal cancer
17. EP-1496 Feasibility of carbon ion radiotherapy for the melanoma of the lower genital tract
18. EP-1968 Respiratory-gated carbon-ion beam treatments of abdominal targets: clinical introduction of 4DMRI
19. PO-0716 Skull-base chordoma treated with proton and carbon ion radiotherapy : CNAO clinical experience
20. EP-1160 Quantifying the impact of radiologic revision in head and neck cancer: monoinstitutional experience
21. EP-1497 Particle radiotherapy for re-irradiation of pelvic recurrences of gynecological cancer
22. OC-0589 RBE-weighted dose in carbon ion therapy: impact of the RBE model translation on clinical outcomes
23. EP-1188 Carbon ion radiotherapy for recurrent pleomorphic adenoma at CNAO: preliminary results.
24. EP-1183 Proton therapy boost in locally advanced head and neck cancer: toxicity and clinical outcome
25. EP-1147 Local control rate in patients with skull-base chondrosarcoma treated with particle therapy
26. EP-1189 Adenoid Cystic Carcinoma Of The Head And Neck Treated With Carbon Ion Radiotherapy At CNAO
27. EP-2051 A comparative analysis of MR signal normalization methods during proton therapy treatment
28. PV-0311 MRI-based tumour control probability model in particle therapy
29. PO-084 Quantification of the impact of radiologic imaging revision in Head and Neck cancer
30. PO-133: Occult lymphnode metastasis in early stage OPC treated with TORS without neck lymphnodes dissection
31. Splitting and accelerating Gaussian beam modulated by Mittag Leffler function
32. 2830 A combined modality treatment with primary chemotherapy followed by Transoral Laser Microsurgery in intermediate stage laryngeal squamous cell carcinoma: A phase II study
33. PO-058: Primary chemotherapy followed by Transoral Laser Microsurgery and early laryngeal squamous cell carcinoma
34. Generation of optical vortices by fractional derivative
35. 67PD LONG-TERM OUTCOMES OF A PILOT CT-SCREENING STUDY FOR LUNG CANCER
36. P316 PREVALENCE OF OVERNUTRITION IN DYSPEPTIC CHILDREN
37. Diffraction patterns from a phyllotaxis-type arrangement
38. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer
39. Langerhans' cell histiocytosis
40. AN IMPROVED TEST TO IDENTIFY aPC-RESISTANT FACTOR V-LEIDEN
41. Protein C and protein S levels in uremic patients before and after dialysis
42. Functional protein S in women with lupus anticoagulant inhibitor
43. Protein S activity in patients with heredofamilial protein S deficiency and in patients with juvenile venous thrombosis. Results of a functional method
44. Protein S in patients with antiphospholipid antibodies syndrome
45. A prothrombin time-based functional assay of protein S
46. Clinical models of phase I for the study of nootropic drugs
47. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.